Status:
COMPLETED
Micro-environment Involvement in Muscle Alteration Induced
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
APARD Fonds de dotation
Conditions:
Chronic Obstructive Pulmonary Disease
Exacerbations
Eligibility:
All Genders
40-85 years
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is characterized by persistent airway obstruction and inflammatory response of the lungs and bronchi. Episodes of exacerbations contribute to increase the ...
Eligibility Criteria
Inclusion
- Inclusion criteria 1/ for COPD patients hospitalized for exacerbation:
- Hospitalization for COPD exacerbation 2/ for COPD patients
- COPD patients GOLD II à IV
- Not having followed respiratory réhabilitation stay for at least one year 3/ for Healthy subjects
- healthy and sedentary (Voorips score \<9)
- Exclusion criteria:
- for COPD patients hospitalized for exacerbation:
- concomitant acute cardiac évent
- trachéal intubation with mechanical ventilation
- chronic respiratory disease other than COPD
- locomotor, neurologic or psychiatric comorbidities
- for COPD patients
- Exacerbation with récent hospitalization (\<4 weeks)
- Neurologic comorbidity
- for Healthy subjects - long term drug treatment with proven central effects
Exclusion
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2020
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04448626
Start Date
March 1 2020
End Date
May 30 2020
Last Update
June 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295